XERIS BIOPHARMA HLDGS INC COM USD0.0001 financial statements, including revenue, expenses, profit, and loss

The total revenue of 0A8E for the last quarter is 48.06 M USD, and it's 18.28% higher compared to the previous quarter. The net income of Q2 24 is -15.01 M USD.